menu
    • menu

    Company profile for Solu Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Solu Therapeutics, a precision-medicine company, is developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The proprietary CyTaC (Cytotoxicity Targeting Chimera) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets providing the capability to develop next-generation medicines that harness the power of biologics with the vast target bindin...
    Solu Therapeutics, a precision-medicine company, is developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The proprietary CyTaC (Cytotoxicity Targeting Chimera) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solu TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    15 Necco Street, 7th Floor, Boston, MA 02210, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://solutherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/solu-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Solu Therapeutics Presents STX-0712 for CMML, AML at ASH
    Solu Therapeutics Presents STX-0712 for CMML, AML at ASH

    02 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/solu-therapeutics-announces-presentation-of-trial-in-progress-on-stx-0712-for-treatment-of-chronic-myelomonocytic-leukemia-and-acute-myeloid-leukemia-at-ash-annual-meeting-302630130.html

    PR NEWSWIRE
    02 Dec 2025
    Share Share
    Solu Therapeutics to Present Data on STX-0712 for Leukemia at ASH
    Solu Therapeutics to Present Data on STX-0712 for Leukemia at ASH

    02 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/solu-therapeutics-to-present-first-preclinical-data-of-stx-0712-for-the-treatment-of-chronic-myelomonocytic-leukemia-and-acute-myeloid-leukemia-at-ash-annual-meeting-302317441.html

    PR NEWSWIRE
    02 Dec 2024
    Share Share
    Solu Appoints Sergio Santillana As Chief Medical Officer
    Solu Appoints Sergio Santillana As Chief Medical Officer

    10 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/solu-therapeutics-strengthens-leadership-team-with-appointment-of-sergio-santillana-md-as-chief-medical-officer-302243220.html

    PR NEWSWIRE
    10 Sep 2024
    Share Share
    Solu Therapeutics Appoints Michael Boretti, Ph.D., as Chief Business Officer
    Solu Therapeutics Appoints Michael Boretti, Ph.D., as Chief Business Officer

    19 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240319208421/en

    BUSINESSWIRE
    19 Mar 2024
    Share Share
    Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and CEO
    Solu Therapeutics Appoints Philip Vickers, Ph.D., as President and CEO

    11 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230911137362/en

    BUSINESSWIRE
    11 Sep 2023
    Share Share
    Solu Therapeutics Announces Presentation at ACS Symposium
    Solu Therapeutics Announces Presentation at ACS Symposium

    15 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230815464221/en

    BUSINESSWIRE
    15 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search